(Q42516531)

1 November 2017

title

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course (English)

1 reference

multiple endocrine neoplasia type 2B

1 November 2017

1 reference

1 reference

Leboulleux S

1

1 reference

1 November 2017

Travagli JP

2

1 reference

1 November 2017

Caillou B

3

1 reference

1 November 2017

Laplanche A

4

1 reference

1 November 2017

Bidart JM

5

1 reference

1 November 2017

Schlumberger M

6

1 reference

1 November 2017

Baudin E

7

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

1 November 2017

1 reference

1 November 2017

volume

94

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

44-50

1 reference

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2B

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Multiple Endocrine Neoplasia Type IIb: The Most Aggressive Form of Medullary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Relatively good prognosis of multiple endocrine neoplasia type 2B in Japanese: review of cases in Japan and analysis of genetic changes in tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

The Natural Course of Multiple Endocrine Neoplasia Type iib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

A note on quantifying follow-up in studies of failure time

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Estimation of confidence limits for the cumulative probability of survival in life table analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Early diagnosis and thyroidectomy in multiple endocrine neoplasia, type 2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Multiple endocrine syndrome type IIb in early childhood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Mucosal ganglioneuromatosis, medullary thyroid carcinoma, and pheochromocytoma: multiple endocrine neoplasia, type 2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Medullary carcinoma of the thyroid before age 2 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Multiple endocrine neoplasia type 2B: more than an endocrine disorder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Long-term follow-up of patients with medullary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10205

7 January 2021

Identifiers

DOI

10.1002/CNCR.10205

1 reference

1 November 2017

1 reference